HMD Develops Dispojekt To Help Reduce Needle Stick Injuries

New Delhi: Hindustan Syringes and Medical Devices (HMD) has launched first-of-its kind Dispojekt single use syringes with safety needle, which further strengthens India’s position in becoming global powerhouse in medical devices.

With the revolutionary Dispojekt safety syringes, HMD aims to reduce prevalence of accidental Needle Stick Injuries (NSIs) among health workers, reduction of infection control cost and that of disposal and training, offering a long term positive financial impact on the healthcare sector. Domestic manufactured, technologically advanced products will provide India a global edge in the realm of R&D and leapfrog indigenous players to meet the highly demanding global market for sharp injury prevention syringes.

The use of safety needles in healthcare settings offer numerous cost benefits. They reduce healthcare worker injuries, lowering costs from potential disease treatment and potential long-term health issues. By minimising needle stick injuries, they also decrease expenses for post-exposure prophylaxis and associated healthcare costs. Moreover, safety needles mitigate compensation claims, absenteeism, and can lead to lower health insurance premiums, while also reducing product and packaging footprints for cost and environmental savings. They assist in creating a safer and more reliable workplace environment for healthcare workers.

According to research, the prevalence of NSIs among healthcare workers in India is between 57% and 73%. In fact, approximately 54% of NSIs are reported because of using hypodermic needles. Many instances of NSIs go unreported, making it a way more serious problem than it appears.

Related Posts

  • Pharma
  • March 22, 2025
  • 68 views
SHRC orders criminal proceedings against fake doctor

Thiruvananthapuram:  The state human rights commission (SHRC) chairperson Justice Alexander Thomas has ordered the Medical Council Registrar to initiate criminal proceedings under the Kerala Medical Practitioners Act 2021 against a…

  • Pharma
  • March 22, 2025
  • 76 views
Karnataka home to hundreds of startups in med, pharma sectors: Minister MB Patil

BENGALURU: Karnataka is emerging as a key player in the dermatology and cosmetic medical treatment sectors, with significant investment opportunities coming up, particularly in the upcoming KWIN City project, said…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

SHRC orders criminal proceedings against fake doctor

SHRC orders criminal proceedings against fake doctor

Karnataka home to hundreds of startups in med, pharma sectors: Minister MB Patil

Karnataka home to hundreds of startups in med, pharma sectors: Minister MB Patil

Piramal Pharma arm, BrePco Biopharma get UKMHRA approval for Neoatricon in UK

Piramal Pharma arm, BrePco Biopharma get UKMHRA approval for Neoatricon in UK

Medical shop sealed for illegal sale of psychotropic drugs

Medical shop sealed for illegal sale of psychotropic drugs

Popular diabetes drug, Mounjaro, launched in India

Popular diabetes drug, Mounjaro, launched in India

Pharma industry says UK pricing revenue unsustainable, blocking investments

Pharma industry says UK pricing revenue unsustainable, blocking investments